Saleh Danish, Najjar Malek, Zelic Matija, Shah Saumil, Nogusa Shoko, Polykratis Apostolos, Paczosa Michelle K, Gough Peter J, Bertin John, Whalen Michael, Fitzgerald Katherine A, Slavov Nikolai, Pasparakis Manolis, Balachandran Siddharth, Kelliher Michelle, Mecsas Joan, Degterev Alexei
Medical Scientist Training Program, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111.
Program in Neuroscience, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111.
J Immunol. 2017 Jun 1;198(11):4435-4447. doi: 10.4049/jimmunol.1601717. Epub 2017 May 1.
The innate immune response is a central element of the initial defense against bacterial and viral pathogens. Macrophages are key innate immune cells that upon encountering pathogen-associated molecular patterns respond by producing cytokines, including IFN-β. In this study, we identify a novel role for RIPK1 and RIPK3, a pair of homologous serine/threonine kinases previously implicated in the regulation of necroptosis and pathologic tissue injury, in directing IFN-β production in macrophages. Using genetic and pharmacologic tools, we show that catalytic activity of RIPK1 directs IFN-β synthesis induced by LPS in mice. Additionally, we report that RIPK1 kinase-dependent IFN-β production may be elicited in an analogous fashion using LPS in bone marrow-derived macrophages upon inhibition of caspases. Notably, this regulation requires kinase activities of both RIPK1 and RIPK3, but not the necroptosis effector protein, MLKL. Mechanistically, we provide evidence that necrosome-like RIPK1 and RIPK3 aggregates facilitate canonical TRIF-dependent IFN-β production downstream of the LPS receptor TLR4. Intriguingly, we also show that RIPK1 and RIPK3 kinase-dependent synthesis of IFN-β is markedly induced by avirulent strains of Gram-negative bacteria, and , and less so by their wild-type counterparts. Overall, these observations identify unexpected roles for RIPK1 and RIPK3 kinases in the production of IFN-β during the host inflammatory responses to bacterial infection and suggest that the axis in which these kinases operate may represent a target for bacterial virulence factors.
先天性免疫反应是抵御细菌和病毒病原体的初始防御的核心要素。巨噬细胞是关键的先天性免疫细胞,在遇到病原体相关分子模式时会通过产生细胞因子(包括IFN-β)做出反应。在本研究中,我们确定了RIPK1和RIPK3这一对同源丝氨酸/苏氨酸激酶在指导巨噬细胞中IFN-β产生方面的新作用,这两种激酶先前与坏死性凋亡和病理性组织损伤的调节有关。使用遗传和药理学工具,我们表明RIPK1的催化活性指导小鼠中由LPS诱导的IFN-β合成。此外,我们报告在抑制半胱天冬酶后,使用LPS在骨髓来源的巨噬细胞中可以以类似方式引发RIPK1激酶依赖性的IFN-β产生。值得注意的是,这种调节需要RIPK1和RIPK3两者的激酶活性,但不需要坏死性凋亡效应蛋白MLKL。从机制上讲,我们提供证据表明坏死小体样的RIPK1和RIPK3聚集体促进LPS受体TLR4下游典型的TRIF依赖性IFN-β产生。有趣的是,我们还表明无毒力的革兰氏阴性菌菌株能显著诱导RIPK1和RIPK3激酶依赖性的IFN-β合成,而野生型菌株诱导作用较小。总体而言,这些观察结果确定了RIPK1和RIPK3激酶在宿主对细菌感染的炎症反应中IFN-β产生中的意外作用,并表明这些激酶发挥作用的轴可能代表细菌毒力因子的一个靶点。